<p>Comparison of PLA<sub>2</sub> activities in the healthy control (normal colonoscopy; n = 77) and CRC (n = 38) groups. A. Comparison of PLA<sub>2</sub> activities in the healthy (n = 79) and other cancer groups. Lung cancer (LC, n = 95), bladder cancer (BC, n = 31) and pancreatic cancer (PC, n = 38). The distribution of the natural and individual groups of PLA<sub>2</sub> activities were analyzed as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0057081#s2" target="_blank">Materials and Methods</a>. The mean values of PLA<sub>2</sub> activities were presented by the “+” in the figure. <b>*</b><i>P</i><0.05; <b>**</b><i>P</i><0.01; <b>***</b><i>P</i><0.001.</p
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
Limited studies have been performed to associate abnormal phospholipid (PL) profile and disease acti...
Only in recent years have phospholipase A2 enzymes (PLA2s) emerged as cancer targets. In this work, ...
Only in recent years have phospholipase A2 enzymes (PLA2s) emerged as cancer targets. In this work, ...
<p>CRC cases vs. healthy subjects. A. All cancers vs. healthy subjects in the 2nd set. B. Lung cance...
<p>CRC cases vs. healthy subjects. A. All cancer cases vs. healthy subjects in the second set. B. Lu...
<p>PLA2 activity comparison in males and females in the healthy and the CRC groups. A. PLA2 activity...
Background/Aim: despite the rapidly accumulating histopathological data reporting differences in the...
<p>Comparison of PLA2 activities between “non-alcohol” and “alcohol” groups with the healthy and CRC...
The relationship between plasma levels of total phospholipids (PL) and/or PL fractions and neoplasti...
Limited studies have been performed to associate abnormal phospholipid (PL) profile and disease acti...
The relationship between plasma levels of total phospholipids (PL) and/or PL fractions and neoplasti...
<p><b>A</b>, Examples of PLAC1 detection by IHC in tumor biopsies from subjects with DCIS, ER<sup>+<...
<p>(A) PLS scores and (B) loadings of LV1 and LV2 from PLS regression correlating the metabolic prof...
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
Limited studies have been performed to associate abnormal phospholipid (PL) profile and disease acti...
Only in recent years have phospholipase A2 enzymes (PLA2s) emerged as cancer targets. In this work, ...
Only in recent years have phospholipase A2 enzymes (PLA2s) emerged as cancer targets. In this work, ...
<p>CRC cases vs. healthy subjects. A. All cancers vs. healthy subjects in the 2nd set. B. Lung cance...
<p>CRC cases vs. healthy subjects. A. All cancer cases vs. healthy subjects in the second set. B. Lu...
<p>PLA2 activity comparison in males and females in the healthy and the CRC groups. A. PLA2 activity...
Background/Aim: despite the rapidly accumulating histopathological data reporting differences in the...
<p>Comparison of PLA2 activities between “non-alcohol” and “alcohol” groups with the healthy and CRC...
The relationship between plasma levels of total phospholipids (PL) and/or PL fractions and neoplasti...
Limited studies have been performed to associate abnormal phospholipid (PL) profile and disease acti...
The relationship between plasma levels of total phospholipids (PL) and/or PL fractions and neoplasti...
<p><b>A</b>, Examples of PLAC1 detection by IHC in tumor biopsies from subjects with DCIS, ER<sup>+<...
<p>(A) PLS scores and (B) loadings of LV1 and LV2 from PLS regression correlating the metabolic prof...
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
The lipid mediator platelet-activating factor (PAF) plays a role in cancer. We investigated its pres...
Limited studies have been performed to associate abnormal phospholipid (PL) profile and disease acti...